Mymetics Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYMX research report →
About the company
Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya. The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology and Vaccinology, focusing on the development and production of virosome-based vaccine formulations for a malaria transmission-blocking agent.
- CEO
- Ronald Kempers
- IPO
- 1999
- Employees
- 2
- HQ
- Epalinges, CH
Price Chart
- Market Cap
- $46
- P/E
- -0.02
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -36.02
- Div Yield
- 0.00%
- Gross Margin
- -47966.67%
- Op Margin
- -58166.67%
- Net Margin
- -160166.67%
- ROE
- 7.69%
- ROIC
- -24.57%
- Revenue
- $3.00K · 0.00%
- Net Income
- $-4,805,000 · -1.59%
- EPS
- $-0.02 · 32.77%
- Op Income
- $-1,745,000
- FCF YoY
- 1.11%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.13
- Avg Volume
- 1
Get TickerSpark's AI analysis on MYMX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 9, 15 | KEMPERS Ronald Hugo Gerard | other | 5,000,000 |
| Jan 31, 06 | Round Enterprises, Ltd. | other | 0 |
| Jan 31, 06 | Round Enterprises, Ltd. | other | 0 |
| Oct 4, 13 | Fleury Sylvain | other | 800,000 |
| Dec 31, 09 | Fleury Sylvain | other | 350,000 |
| Jun 18, 07 | Fleury Sylvain | other | 0 |
| Jun 17, 10 | Stegmann Antonius Johannes | other | 4,000,000 |
| Jun 17, 10 | Stegmann Antonius Johannes | other | 150,000 |
| Dec 27, 13 | KEMPERS Ronald Hugo Gerard | sell | 3,000,000 |
| Dec 27, 13 | KEMPERS Ronald Hugo Gerard | other | 3,000,000 |
Our MYMX coverage
Recent articles, reports, and earnings notes.
No research on MYMX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MYMX report →Similar companies
Peers in the same neighborhood.